SO
SMMT icon

STRS Ohio’s Summit Therapeutics SMMT Stock Holding History

STRS Ohio’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5K Buy
2,848
+54
+2% +$958 ﹤0.01% 2044
2026
Q1 		$53K Sell
2,794
-4
-0.1% -$65 ﹤0.01% 1924
2025
Q4 		$48.9K Buy
2,798
+5
+0.2% +$94 ﹤0.01% 1983
2025
Q3 		$57.7K Sell
2,793
-34,106
-92% -$827K ﹤0.01% 1983
2025
Q2 		$785K Buy
+36,899
New +$841K ﹤0.01% 1010
2021
Q3 		– Sell
-5,200
Closed -$38K – 2313
2021
Q2 		$38K Buy
+5,200
New +$34.1K ﹤0.01% 2139

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

STRS Ohio's SMMT Position: Q2 2026 in Review

STRS Ohio increased its Summit Therapeutics (SMMT) stake by 1.9% in Q2 2026, buying an estimated $958 and bringing the position to 2,848 shares worth $41.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

STRS Ohio first reported a position in SMMT in Q2 2021 and has held it in 6 quarters since. The position peaked at $785K in Q2 2025. 243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • STRS Ohio held 2,848 shares of Summit Therapeutics worth $41.5K as of Q2 2026.
  • STRS Ohio bought 54 Summit Therapeutics shares in Q2 2026, an estimated $958.
  • Summit Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2044 holding.
  • STRS Ohio first reported a position in Summit Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • STRS Ohio's Summit Therapeutics position peaked at $785K in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.